Fintel reports that on April 24, 2025, Maxim Group initiated coverage of Castellum (NYSEAM:CTM) with a Buy recommendation.

Maxim Group analyst Michael Okunewitch maintained a Buy rating on Rezolute (RZLT – Research Report) yesterday and set a price target of $15.00.

In a report released today, Tate Sullivan from Maxim Group reiterated a Buy rating on NioCorp Developments (NB – Research Report), with a price ...

B2i Digital Will Highlight U.S.-focused Mining Companies Ahead of the May 6th Virtual Event to Its Community of Over 1.2 ...

Tom Forte, Maxim Group analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on how the tech sector is getting hit by tariffs, how Apple might shift it's production or move prices, and more ...

Our role is to equip investors with the information they need to understand better the companies and opportunities shaping the U.S. critical miner ...

We recently published a list of 13 Best Precious Metals Stocks to Buy According to Analysts. In this article, we are going to ...

Analysts from Maxim Group have noted that Checha’s revenue and bottom-line results exceeded projections, while their outlook remains positive. Additionally, the company plans to leverage AI and ...

Fintel reports that on April 7, 2025, Maxim Group initiated coverage of Intchains Group Limited - Depositary Receipt () (NasdaqCM:ICG) with a Buy recommendation. As of April 2, 2025, the average ...

Detailed price information for Lineage Cell Therapeutics Inc (LCTX-A) from The Globe and Mail including charting and trades.